These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 33582388
1. New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263. Ofori E, Onyameh EK, Gonela UM, Voshavar C, Bricker B, Swanson TL, Eshleman AJ, Schmachtenberg JL, Bloom SH, Janowsky AJ, Ablordeppey SY. Eur J Med Chem; 2021 Mar 15; 214():113243. PubMed ID: 33582388 [Abstract] [Full Text] [Related]
2. A study of the structure-affinity relationship in SYA16263; is a D2 receptor interaction essential for inhibition of apormorphine-induced climbing behavior in mice? Onyameh EK, Bricker BA, Eyunni SVK, Voshavar C, Gonela UM, Ofori E, Jenkins A, Ablordeppey SY. Bioorg Med Chem; 2021 Jan 15; 30():115943. PubMed ID: 33338898 [Abstract] [Full Text] [Related]
3. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR. Intagliata S, Modica MN, Pittalà V, Salerno L, Siracusa MA, Cagnotto A, Salmona M, Romeo G. Bioorg Med Chem Lett; 2016 Aug 15; 26(16):4052-6. PubMed ID: 27396505 [Abstract] [Full Text] [Related]
4. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents. Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V. J Med Chem; 2004 Dec 16; 47(26):6616-24. PubMed ID: 15588097 [Abstract] [Full Text] [Related]
5. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT7 receptor agents with antidepressant activity. Kucwaj-Brysz K, Kurczab R, Jastrzębska-Więsek M, Żesławska E, Satała G, Nitek W, Partyka A, Siwek A, Jankowska A, Wesołowska A, Kieć-Kononowicz K, Handzlik J. Eur J Med Chem; 2018 Mar 10; 147():102-114. PubMed ID: 29425815 [Abstract] [Full Text] [Related]
6. Synthesis and evaluation of arylpiperazines derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR ligands. Kumar JSD, Majo VJ, Prabhakaran J, Mann JJ. Bioorg Med Chem Lett; 2014 Oct 01; 24(19):4759-4762. PubMed ID: 25182564 [Abstract] [Full Text] [Related]
7. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. Liégeois JF, Deville M, Dilly S, Lamy C, Mangin F, Résimont M, Tarazi FI. J Med Chem; 2012 Feb 23; 55(4):1572-82. PubMed ID: 22268448 [Abstract] [Full Text] [Related]
8. New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo. Valhondo M, Marco I, Martín-Fontecha M, Vázquez-Villa H, Ramos JA, Berkels R, Lauterbach T, Benhamú B, López-Rodríguez ML. J Med Chem; 2013 Oct 24; 56(20):7851-61. PubMed ID: 24050112 [Abstract] [Full Text] [Related]
9. 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux. Huang M, Horiguchi M, Felix AR, Meltzer HY. Neuroreport; 2012 May 09; 23(7):436-40. PubMed ID: 22415605 [Abstract] [Full Text] [Related]
10. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. Medina RA, Sallander J, Benhamú B, Porras E, Campillo M, Pardo L, López-Rodríguez ML. J Med Chem; 2009 Apr 23; 52(8):2384-92. PubMed ID: 19326916 [Abstract] [Full Text] [Related]
11. New dual ligands for the D2 and 5-HT1A receptors from the group of 1,8-naphthyl derivatives of LCAP. Zaręba P, Jaśkowska J, Śliwa P, Satała G. Bioorg Med Chem Lett; 2019 Aug 15; 29(16):2236-2242. PubMed ID: 31253532 [Abstract] [Full Text] [Related]
12. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines. Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R. J Med Chem; 2001 Dec 06; 44(25):4431-42. PubMed ID: 11728188 [Abstract] [Full Text] [Related]
13. Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands. Modica MN, Intagliata S, Pittalà V, Salerno L, Siracusa MA, Cagnotto A, Salmona M, Romeo G. Bioorg Med Chem Lett; 2015 Apr 01; 25(7):1427-30. PubMed ID: 25759032 [Abstract] [Full Text] [Related]
14. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies. Sagnes C, Fournet G, Satala G, Bojarski AJ, Joseph B. Eur J Med Chem; 2014 Mar 21; 75():159-68. PubMed ID: 24531229 [Abstract] [Full Text] [Related]
15. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants. Martínez-Esparza J, Oficialdegui AM, Pérez-Silanes S, Heras B, Orús L, Palop JA, Lasheras B, Roca J, Mourelle M, Bosch A, Del Castillo JC, Tordera R, Del Río J, Monge A. J Med Chem; 2001 Feb 01; 44(3):418-28. PubMed ID: 11462981 [Abstract] [Full Text] [Related]
16. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors. Bielenica A, Kozioł AE, Struga M. Mini Rev Med Chem; 2013 Aug 01; 13(10):1516-39. PubMed ID: 24568298 [Abstract] [Full Text] [Related]
17. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation. Jurczyk S, Kołaczkowski M, Maryniak E, Zajdel P, Pawłowski M, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E, Bojarski AJ, Charakchieva-Minol S, Duszyńska B, Nowak G, Maciag D. J Med Chem; 2004 May 06; 47(10):2659-66. PubMed ID: 15115407 [Abstract] [Full Text] [Related]
18. Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity. Bucki A, Marcinkowska M, Śniecikowska J, Więckowski K, Pawłowski M, Głuch-Lutwin M, Gryboś A, Siwek A, Pytka K, Jastrzębska-Więsek M, Partyka A, Wesołowska A, Mierzejewski P, Kołaczkowski M. J Med Chem; 2017 Sep 14; 60(17):7483-7501. PubMed ID: 28763213 [Abstract] [Full Text] [Related]
19. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB. J Med Chem; 2011 May 12; 54(9):3206-21. PubMed ID: 21486038 [Abstract] [Full Text] [Related]
20. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity. Paluchowska MH, Bojarski AJ, Bugno R, Charakchieva-Minol S, Wesołowska A. Arch Pharm (Weinheim); 2003 Apr 12; 336(2):104-10. PubMed ID: 12761763 [Abstract] [Full Text] [Related] Page: [Next] [New Search]